KMT2B Is Selectively Required for Neuronal Transdifferentiation, and Its Loss Exposes Dystonia Candidate Genes
Giulia Barbagiovanni,
Pierre-Luc Germain,
Michael Zech,
Sina Atashpaz,
Pietro Lo Riso,
Agnieszka D’Antonio-Chronowska,
Erika Tenderini,
Massimiliano Caiazzo,
Sylvia Boesch,
Robert Jech,
Bernhard Haslinger,
Vania Broccoli,
Adrian Francis Stewart,
Juliane Winkelmann,
Giuseppe Testa
Affiliations
Giulia Barbagiovanni
Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, 20139 Milan, Italy
Pierre-Luc Germain
Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, 20139 Milan, Italy
Michael Zech
Institut für Neurogenomik, Helmholtz Zentrum München, 85764 Munich, Germany; Klinik und Poliklinik für Neurologie, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany
Sina Atashpaz
Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, 20139 Milan, Italy
Pietro Lo Riso
Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, 20139 Milan, Italy
Agnieszka D’Antonio-Chronowska
Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, 20139 Milan, Italy
Erika Tenderini
Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, 20139 Milan, Italy
Massimiliano Caiazzo
San Raffaele Scientific Institute, 20132 Milan, Italy
Sylvia Boesch
Department of Neurology, Medical University Innsbruck, 6020 Innsbruck, Austria
Robert Jech
Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General Faculty Hospital, 12821 Prague, Czech Republic
Bernhard Haslinger
Klinik und Poliklinik für Neurologie, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany
Vania Broccoli
San Raffaele Scientific Institute, 20132 Milan, Italy; National Research Council (CNR), Institute of Neuroscience, 20129 Milan, Italy
Adrian Francis Stewart
Genomics, Biotechnology Center, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01069 Dresden, Germany
Juliane Winkelmann
Institut für Neurogenomik, Helmholtz Zentrum München, 85764 Munich, Germany; Lehrstuhl für Neurogenetik und Institut für Humangenetik, Technische Universität München, 81675 Munich, Germany; Munich Cluster for Systems Neurology, SyNergy, 81829 Munich, Germany
Giuseppe Testa
Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, 20139 Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy; Corresponding author
Summary: Transdifferentiation of fibroblasts into induced neuronal cells (iNs) by the neuron-specific transcription factors Brn2, Myt1l, and Ascl1 is a paradigmatic example of inter-lineage conversion across epigenetically distant cells. Despite tremendous progress regarding the transcriptional hierarchy underlying transdifferentiation, the enablers of the concomitant epigenome resetting remain to be elucidated. Here, we investigated the role of KMT2A and KMT2B, two histone H3 lysine 4 methylases with cardinal roles in development, through individual and combined inactivation. We found that Kmt2b, whose human homolog’s mutations cause dystonia, is selectively required for iN conversion through suppression of the alternative myocyte program and induction of neuronal maturation genes. The identification of KMT2B-vulnerable targets allowed us, in turn, to expose, in a cohort of 225 patients, 45 unique variants in 39 KMT2B targets, which represent promising candidates to dissect the molecular bases of dystonia. : Barbagiovanni et al. demonstrate that KMT2B, in contrast to KMT2A, is fundamental for the epigenetic and transcriptomic resetting underlying transdifferentiation of fibroblasts into induced neuronal cells (iNs), acting both in the suppression of alternative fates and in the promotion of iN maturation. Transdifferentiation-specific KMT2B targets reveal dystonia-causative gene candidates. Keywords: KMT2B, histone H3 lysine 4 methylation, transdifferentiation, epigenetics, induced neuronal cells, mouse embryonic fibroblasts, myocytes, dystonia, cell fate conversion, MLL2